There is movement in states across the country to pass laws or guidelines that permit schools to stock albuterol with a prescription and administer to a student believed to be in respiratory distress.
Proposed legislation that would standardize asthma action plans and access to emergency asthma medications at school.
Telehealth is an interactive telecommunications system that permits real-time, face-to-face communication between healthcare professionals and their patients who are located at different sites. It is an emerging and critical component of healthcare that addresses a number of challenging problems of our current healthcare system.
Is your state prepared to respond to a life-threatening allergic reaction in a restaurant or theme park? Many states are passing entity epinephrine laws that permit public venues to stock emergency supplies of epinephrine auto-injectors. Check the status of your state here.
Allergy & Asthma Network supports the dialogue on climate change and health and is committed to opposing any attempts to block, weaken or delay protections against ozone, carbon and particle pollution.
State laws that allow or require anaphylaxis emergency preparedness plans that permit schools to stock emergency supplies of epinephrine auto-injectors
Allergy testing and immunotherapy schemes sweeping the country put patients at risk and fleece government and private insurance. How can you ensure quality care for your family?
Allergy & Asthma Network believes every person with asthma deserves medical care in accordance with national guidelines. The National Asthma Education and Prevention Program (NAEPP) Expert Panel Report #3 (EPR-3) is a comprehensive, evidence-based set of guidelines for healthcare professionals treating asthma.
Allergy & Asthma Network campaign protecting students’ rights to carry and self-administer prescribed asthma and anaphylaxis medications at school.
Visit our Online Advocacy Center to find out about current legislation and how to contact your legislators.
For questions and to get involved in Allergy & Asthma Network’s advocacy efforts, contact canderson@AllergyAsthmaNetwork.org or 800.878.4403.